Skip to main content
TipRanks
Go Ultimate75% OFF

Bioline Rx (BLRX) Q3 2024 Earnings Report

3 Followers

IL:BLRX Q3 2024 EPS Results

Actual EPS
ILA 0.00
Consensus EPS
-ILA 0.98
Beat/Miss
Beat by +ILA 0.98
One Year Ago EPS
-ILA 6.51

IL:BLRX Q3 2024 Revenue Results

Actual Revenue
ILA 1.84B
Expected Revenue
ILA 1.72B
Beat/Miss
Beat by +ILA 113.59M
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2024
Date
11/25/2024
Time
Before Open
Conference Call
Monday, November 25, 2024
IL:BLRX Upcoming Earnings

Bioline Rx's next earnings date is estimated for November 23, 2026, based on past reporting schedules.

Q3 2024 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

IL:BLRX Earnings History

IL:BLRX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 23, 20262026 (Q3)-0.33-0――
Aug 31, 20262026 (Q2)0.000.000―
May 27, 20262026 (Q1)-0.650.000―
Mar 23, 20262025 (Q4)-0.330.00-0.98100.00% (+0.98)
Nov 24, 20252025 (Q3)-0.330.000―
Aug 14, 20252025 (Q2)-0.330.000―
May 27, 20252025 (Q1)―-0―
Mar 31, 20252024 (Q4)-0.650.000―
Nov 25, 20242024 (Q3)-0.980.00-6.51100.00% (+6.51)
Aug 15, 20242024 (Q2)―0.00-6.51100.00% (+6.51)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed